15mg vial of tirzepatide Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Tirzepatide 15Mg T15 - Brand

Retatrutide is an investigational GLP-1/GIP/glucagon receptor agonist supplied for qualified research into triple-incretin pathway biology

This peptide has gained significant interest in research settings for its receptor binding profile and pharmacological properties

You should avoid both Ozempic (semaglutide) and tirzepatide while breastfeeding due to insufficient human safety data, though emerging evidence suggests sema...

Already on Wegovy or Mounjaro

As patents of Semaglutide begin to expire globally, dozens of pharmaceutical companies are preparing to enter a market currently dominated by Novo Nordisk through blockbuster brands like Ozempic and Wegovy